Get the Stockscreener App
0.4216
1.95%
-0.0084
Shuttle Pharmaceuticals Holdings Inc stock is currently priced at $0.4216, with a 24-hour trading volume of 35,909.
It has seen a -1.95% decreased in the last 24 hours and a -3.74% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $0.4223 pivot point. If it approaches the $0.4054 support level, significant changes may occur.
Previous Close:
$0.43
Open:
$0.43
24h Volume:
35,909
Market Cap:
$7.03M
Revenue:
-
Net Income/Loss:
$-6.59M
P/E Ratio:
-1.1095
EPS:
-0.38
Net Cash Flow:
$-5.58M
1W Performance:
+5.61%
1M Performance:
-3.74%
6M Performance:
-15.68%
1Y Performance:
-71.12%
1D Range:
$0.4156
$0.43
52W Range:
$0.35
$2.75
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Company Profile
Name
Shuttle Pharmaceuticals Holdings Inc
Sector
Phone
240 403 4212
Address
One Research Court, Suite 450, Rockville
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Latest News
Shuttle Pharmaceuticals to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024
GlobeNewswire Inc.
Why Macatawa Bank Shares Are Trading Higher By Around 37%; Here Are 20 Stocks Moving Premarket
Benzinga
Shuttle Pharmaceuticals to Present at the Emerging Growth Conference on April 4, 2024
GlobeNewswire Inc.
Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Benzinga
Why Rocket Lab Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket
Benzinga
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Financials Data
Shuttle Pharmaceuticals Holdings Inc (SHPH) Net Income 2024
SHPH net income (TTM) was -$6.59 million for the quarter ending December 31, 2023, a -117.70% decrease year-over-year.
Shuttle Pharmaceuticals Holdings Inc (SHPH) Cash Flow 2024
SHPH recorded a free cash flow (TTM) of -$5.58 million for the quarter ending December 31, 2023, a -105.91% decrease year-over-year.
Shuttle Pharmaceuticals Holdings Inc (SHPH) Earnings per Share 2024
SHPH earnings per share (TTM) was -$0.43 for the quarter ending December 31, 2023, a -65.26% decline year-over-year.
Shuttle Pharmaceuticals Holdings Inc Stock (SHPH) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Brown Milton | Director |
Dec 13 '23 |
Sale |
0.46 |
2,921 |
1,353 |
1,094,610 |
About Shuttle Pharmaceuticals Holdings Inc
Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and soft tissue sarcomas; and Doranidazole, an injectable hypoxic cell radiation sensitizer for treatment of pancreatic, lung, and liver cancers. The company was founded in 2012 and is based in Rockville, Maryland.
1.50%
1.58%
Cap:
|
Volume (24h):